{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T02:43:53Z","timestamp":1761101033876,"version":"3.37.3"},"reference-count":13,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"13","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,8,24]]},"DOI":"10.1097\/qad.0b013e32833bedc8","type":"journal-article","created":{"date-parts":[[2010,6,26]],"date-time":"2010-06-26T08:52:33Z","timestamp":1277542353000},"page":"2001-2007","source":"Crossref","is-referenced-by-count":11,"title":["The cytotoxic lymphocyte antigen 4 polymorphisms affect response to hepatitis C virus-specific therapy in HIV(+) patients with acute and chronic hepatitis C virus co-infection"],"prefix":"10.1097","volume":"24","author":[{"given":"Hans Dieter","family":"Nischalke","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Vogel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"Mauss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Axel","family":"Baumgarten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Lutz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc","family":"Danta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Uwe","family":"Naumann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Coenen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tilman","family":"Sauerbruch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00fcrgen K","family":"Rockstroh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulrich","family":"Spengler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacob","family":"Nattermann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-4-20210130","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S1473-3099(04)01059-X","article-title":"HIV and hepatitis C virus co-infection","volume":"4","author":"Rockstroh","year":"2004","journal-title":"Lancet Infect Dis"},{"key":"R3-4-20210130","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1086\/374561","article-title":"Association of CTLA4 polymorphisms with sustained response to interferon and ribavirin therapy for chronic hepatitis C virus infection","volume":"187","author":"Yee","year":"2003","journal-title":"J Infect Dis"},{"key":"R4-4-20210130","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.jhep.2006.09.011","article-title":"Gender-dependent association of CTLA4 polymorphisms with resolution of hepatitis C virus infection","volume":"46","author":"Schott","year":"2007","journal-title":"J Hepatol"},{"key":"R5-4-20210130","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/nri2253","article-title":"The reverse stop-signal model for CTLA4 function","volume":"8","author":"Rudd","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"R6-4-20210130","doi-asserted-by":"crossref","first-page":"6606","DOI":"10.4049\/jimmunol.165.11.6606","article-title":"CTLA-4 gene polymorphism at position 49 in exon 1 reduces the inhibitory function of CTLA-4 and contributes to the pathogenesis of Graves' disease","volume":"165","author":"Kouki","year":"2000","journal-title":"J Immunol"},{"key":"R7-4-20210130","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1056\/NEJMoa011232","article-title":"Treatment of acute hepatitis C with interferon alfa-2b","volume":"345","author":"Jaeckel","year":"2001","journal-title":"N Engl J Med"},{"key":"R8-4-20210130","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/j.1468-1293.2007.00535.x","article-title":"European AIDS Clinical Society (EACS) guidelines for the clinical management and treatment of chronic hepatitis B and C coinfection in HIV-infected adults","volume":"9","author":"Rockstroh","year":"2008","journal-title":"HIV Med"},{"key":"R9-4-20210130","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1177\/135965350601100817","article-title":"Pegylated interferon-alpha for the treatment of sexually transmitted acute hepatitis C in HIV-infected individuals","volume":"11","author":"Vogel","year":"2006","journal-title":"Antivir Ther"},{"key":"R10-4-20210130","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.humimm.2009.03.016","article-title":"Influence of CTLA-4 gene polymorphism in autoimmune and infectious diseases","volume":"70","author":"Fernandez-Mestre","year":"2009","journal-title":"Hum Immunol"},{"key":"R11-4-20210130","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1111\/j.1478-3231.2007.01553.x","article-title":"Recipient cytotoxic T lymphocyte antigen-4 +49 G\/G genotype is associated with reduced incidence of hepatitis B virus recurrence after liver transplantation among Chinese patients","volume":"27","author":"Jiang","year":"2007","journal-title":"Liver Int"},{"key":"R12-4-20210130","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1515\/BC.2008.061","article-title":"Adaptive immune responses to hepatitis C virus: from viral immunobiology to a vaccine","volume":"389","author":"Thimme","year":"2008","journal-title":"Biol Chem"},{"key":"R13-4-20210130","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1084\/jem.191.11.1987","article-title":"Modulation of susceptibility to HIV-1 infection by the cytotoxic T lymphocyte antigen 4 costimulatory molecule","volume":"191","author":"Riley","year":"2000","journal-title":"J Exp Med"},{"key":"R14-4-20210130","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1097\/00002030-200203080-00002","article-title":"CTLA-4 upregulation during HIV infection: association with anergy and possible target for therapeutic intervention","volume":"16","author":"Leng","year":"2002","journal-title":"AIDS"}],"container-title":["AIDS"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00002030-201008240-00004","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,22]],"date-time":"2025-02-22T08:07:53Z","timestamp":1740211673000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00002030-201008240-00004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8,24]]},"references-count":13,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/qad.0b013e32833bedc8","relation":{},"ISSN":["0269-9370"],"issn-type":[{"type":"print","value":"0269-9370"}],"subject":[],"published":{"date-parts":[[2010,8,24]]}}}